|
FDA Gets Drugs to Market Faster Than EMA, Health Canada: Study
The FDA is approving drugs faster than its regulatory peers in Europe and Canada, a new study finds, challenging criticism that the U.S. agency harps on safety at the expense of timely reviews.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives